<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

1 min read

SmartTRAK Publication Alert: Q317 Hemostats and Sealants Quarterly Market Recap

12/18/17 7:11 PM

SmartTRAK Publication Alert Blog Post Social Media - Hemostats and Sealants (4).png

Q317 Market Recap Biosurgery Hemostats & Sealants: Supply Chain Disruptions 

By Doug Devens, Senior Analyst Biosurgery

Surprisingly, the US market for Hemostats and Sealants was down vs Q217 and YoY, an anomaly from historic growth rates, primarily due to supply chain disruptions and softness in the thrombin hemostat segment.

The makeup of the market continues to evolve, as companies consider new indications for their products or bring products to market by capitalizing on trends...

Read entire Market Recap including news, data and analysis...*

*This article can only be viewed by SmartTRAK subscribers to this module.

Request SmartTRAK Wound Care Subscription Info

Topics: Wound Care

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

    Recent Articles